Results 261 to 270 of about 355,709 (346)

Serum histamine in non-small cell lung cancer: An observational study in the context of allergo-oncology. [PDF]

J Int Med Res
Rongrong Z, Wenyue S, Yanyun H, Fengli Z, Lei S.   +4 more
europepmc   +1 more source

Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway

Pediatric Discovery, EarlyView.
ABSTRACT Asthma, chronic pulmonary obstructive disease (COPD), cystic fibrosis, and acute respiratory infections are severe respiratory conditions that significantly contribute to global morbidity and mortality. Airway mucus hypersecretion is an important common pathophysiological and clinical manifestation of these diseases and is closely associated ...
Yuanyuan Zhang, Fuping Yang, Chunyu Yan, Yu Deng, Enmei Liu   +4 more
wiley   +1 more source

A Tale of Two Periods: The Evolution of Determinants and CVD Mortality Risk in Metastatic NSCLC. [PDF]

Rev Cardiovasc Med
Xia J, Pang Y, Yang Y, Teng J, Lin Q.
europepmc   +1 more source

Exploring relationships between tumor mutation burden with immunity and prognosis in lung adenocarcinoma based on weighted gene co‐expression network analysis

Precision Medical Sciences, EarlyView.
This study reveals that high TMB in lung adenocarcinoma correlates with better survival prognosis and lower immune/stromal scores. Through WGCNA and consensus clustering, we identify two LUAD subtypes with distinct prognoses and mutation frequencies, offering novel insights for immunotherapy response prediction and prognosis stratification.
Haiyong Wu, Jinzhuo Ren, Zhipeng Gong, Yan Zhang, Hua Zhang, Weikang Chen, Chenyang Zhao, Tao Fang   +7 more
wiley   +1 more source

Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation. [PDF]

Drug Des Devel Ther
Xu B, Yu Y, Zhang J, Jiang B, Yan L, Chen S, Hu L, Miao Q, Qi Y.   +8 more
europepmc   +1 more source

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early stage (I/II) non-small cell lung cancer (NSCLC). Long-term results of a phase II study

, 2004
Branislav Jeremić, Biljana Miličić, Ljubiša Aćimović, Slobodan Milisavljević   +3 more
openalex   +1 more source

Single-cell RNA-seq reveals gene expression heterogeneity in NSCLC and its link to the immune microenvironment. [PDF]

Discov Oncol
Ren J, Zhang H, Wu H.
europepmc   +1 more source

Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 540-550, March 2025.
ABSTRACT We employed a mechanistic learning approach, integrating on‐treatment tumor kinetics (TK) modeling with various machine learning (ML) models to address the challenge of predicting post‐progression survival (PPS)—the duration from the time of documented disease progression to death—and overall survival (OS) in Head and Neck Squamous Cell ...
Kevin Atsou, Anne Auperin, Jôel Guigay, Sébastien Salas, Sebastien Benzekry   +4 more
wiley   +1 more source

Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]

World J Surg Oncol
Lin M, Chen X, Lin F, Yang Y.
europepmc   +1 more source